Index -
P/E 11.66
EPS (ttm) 3.99
Insider Own 1.25%
Shs Outstand 159.53M
Perf Week 1.15%
Market Cap 7.42B
Forward P/E 10.34
EPS next Y 4.50
Insider Trans 1.54%
Shs Float 157.62M
Perf Month 14.30%
Income 647.73M
PEG 1.17
EPS next Q 0.75
Inst Own 100.39%
Short Float 5.10%
Perf Quarter -7.44%
Sales 6.75B
P/S 1.10
EPS this Y -13.01%
Inst Trans 0.51%
Short Ratio 4.14
Perf Half Y -10.25%
Book/sh 28.87
P/B 1.61
EPS next Y 29.62%
ROA 6.39%
Short Interest 8.04M
Perf Year -15.94%
Cash/sh 0.79
P/C 58.55
EPS next 5Y 10.00%
ROE 15.40%
52W Range 38.97 - 71.60
Perf YTD -6.68%
Dividend Est. -
P/FCF 21.59
EPS past 5Y 45.84%
ROI 7.10%
52W High -35.04%
Beta 1.29
Dividend TTM -
Quick Ratio 1.10
Sales past 5Y 15.82%
Gross Margin 16.32%
52W Low 19.36%
ATR (14) 1.35
Dividend Ex-Date -
Current Ratio 1.86
EPS Y/Y TTM -11.60%
Oper. Margin 8.17%
RSI (14) 61.05
Volatility 2.51% 2.98%
Employees 15800
Debt/Eq 1.01
Sales Y/Y TTM 3.65%
Profit Margin 9.60%
Recom 1.56
Target Price 63.81
Option/Short Yes / Yes
LT Debt/Eq 0.98
EPS Q/Q -45.49%
Payout 0.00%
Rel Volume 0.67
Prev Close 46.33
Sales Surprise -4.17%
EPS Surprise -24.26%
Sales Q/Q -8.81%
Earnings Feb 27 AMC
Avg Volume 1.94M
Price 46.51
SMA20 5.06%
SMA50 7.23%
SMA200 -9.69%
Trades
Volume 1,298,402
Change 0.39%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-01-24 Initiated
Citigroup
Neutral
$49
Oct-13-23 Downgrade
Tudor, Pickering, Holt & Co.
Buy → Hold
Apr-14-23 Resumed
BMO Capital Markets
Outperform
$80
Jan-17-23 Downgrade
Stephens
Overweight → Equal-Weight
$90 → $75
Oct-19-22 Initiated
Jefferies
Buy
$102
Sep-12-22 Initiated
Stifel
Buy
$101
Sep-08-22 Initiated
Scotiabank
Sector Outperform
Apr-25-22 Initiated
Cowen
Market Perform
$80
Jul-16-21 Initiated
Raymond James
Strong Buy
$95
Jul-15-21 Initiated
Evercore ISI
Outperform
$86
Jun-25-21 Upgrade
BMO Capital Markets
Market Perform → Outperform
$82
Jun-09-21 Initiated
Citigroup
Buy
$110
Mar-05-21 Upgrade
JP Morgan
Neutral → Overweight
$69 → $84
Mar-02-21 Initiated
Piper Sandler
Overweight
$95
Oct-21-20 Initiated
Wolfe Research
Outperform
Oct-09-20 Initiated
Tudor Pickering
Buy
$47
Sep-29-20 Initiated
Stephens
Overweight
$54
Sep-28-20 Initiated
Credit Suisse
Outperform
$50
Jul-16-20 Initiated
Berenberg
Buy
$33
Mar-09-20 Upgrade
Goldman
Neutral → Buy
$29 → $37
Show Previous Ratings
Mar-05-24 11:26PM
09:09PM
Mar-04-24 10:38AM
Mar-03-24 04:35PM
Mar-01-24 04:31AM
11:29PM
Loading…
Feb-29-24 11:29PM
12:17PM
09:01AM
01:20AM
(Thomson Reuters StreetEvents)
Feb-27-24 07:00PM
05:27PM
(Associated Press Finance)
05:12PM
04:42PM
Feb-22-24 09:15AM
Feb-21-24 04:43PM
10:00AM
Loading…
Feb-20-24 10:00AM
Feb-14-24 04:42PM
Feb-12-24 07:50AM
Feb-07-24 03:37PM
Jan-31-24 08:02AM
Jan-25-24 07:45AM
Dec-21-23 09:23PM
Dec-19-23 08:38AM
Dec-17-23 12:35PM
Dec-11-23 04:17PM
Dec-05-23 01:34PM
Dec-04-23 08:00AM
Nov-17-23 01:03AM
Nov-16-23 04:16PM
Nov-09-23 02:23PM
07:00PM
Loading…
Nov-07-23 07:00PM
05:06PM
(Associated Press Finance)
04:16PM
Nov-05-23 09:13PM
Nov-01-23 10:01AM
Oct-31-23 10:01AM
Oct-30-23 04:06PM
Oct-27-23 08:35AM
Oct-26-23 04:06PM
Oct-24-23 03:23AM
Oct-18-23 12:05PM
Sep-29-23 02:52PM
Sep-14-23 03:11PM
Sep-11-23 07:00PM
11:43AM
Aug-08-23 08:30PM
07:15PM
06:17PM
04:51PM
Aug-02-23 04:48PM
Jul-24-23 04:47PM
Jul-17-23 04:37PM
Jul-07-23 11:03AM
Jun-26-23 11:35AM
(The Wall Street Journal)
Jun-25-23 07:00AM
(The Wall Street Journal)
Jun-21-23 08:00PM
12:47PM
11:24AM
Jun-12-23 11:00AM
Jun-05-23 01:04PM
08:32AM
Jun-01-23 04:27PM
May-26-23 06:59AM
May-21-23 03:28PM
May-17-23 11:27AM
May-13-23 12:04PM
May-10-23 11:57PM
(Thomson Reuters StreetEvents) +8.57%
04:40PM
03:43PM
May-09-23 07:30PM
07:05PM
04:40PM
07:10AM
May-08-23 06:00AM
May-06-23 10:57AM
May-04-23 04:51AM
May-03-23 01:00AM
May-02-23 04:35PM
10:01AM
Apr-26-23 08:00PM
04:04PM
Apr-24-23 05:52PM
04:35PM
Apr-20-23 08:30AM
Apr-10-23 09:14AM
Apr-03-23 08:00AM
Mar-27-23 07:50AM
Mar-17-23 07:37PM
02:38AM
Mar-03-23 06:38AM
Mar-02-23 06:07AM
Mar-01-23 02:45PM
12:09AM
(Thomson Reuters StreetEvents)
Feb-28-23 01:12PM
06:12AM
Feb-27-23 07:05PM
04:36PM
Feb-21-23 04:36PM
10:00AM
Feb-20-23 10:00AM
Darling Ingredients, Inc. engages in the development and production of natural ingredients from edible and inedible bio-nutrients. It operates through the following segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients. The Feed Ingredients segment includes ingredients business such as fats and proteins used cooking oil, trap grease and food residuals collection, the Rothsay ingredients, and the ingredients and specialty products. The Food Ingredients segment comprises gelatin, natural casings and meat by-products, and specialty products activities. The Fuel Ingredients segment consists of biofuel and bioenergy services. The company was founded in 1882 and is headquartered in Irving, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
STUEWE RANDALL C Chairman and CEO Mar 04 '24 Option Exercise 19.94 61,124 1,218,813 795,128 Mar 06 04:40 PM JANSEN MATTHEW J COO North America Mar 04 '24 Buy 42.76 6,000 256,560 74,065 Mar 05 05:52 PM Stoffel Kurt Director Feb 29 '24 Buy 41.62 8,000 332,960 10,571 Feb 29 05:33 PM MANZI JOSEPH Chief Accounting Officer Nov 20 '23 Buy 43.38 1,025 44,464 6,978 Nov 20 06:10 PM Day Robert W EVP Chief Strategy Officer Nov 16 '23 Buy 41.77 1,950 81,452 3,930 Nov 20 06:09 PM JANSEN MATTHEW J COO North America Nov 15 '23 Buy 44.80 11,113 497,862 59,849 Nov 16 04:45 PM McNutt Patrick EVP Chief Admin Officer Nov 13 '23 Buy 41.88 1,200 50,256 13,947 Nov 14 06:37 PM Adair Charles L Director Nov 13 '23 Buy 41.00 500 20,500 40,122 Nov 14 06:36 PM Adair Charles L Director Nov 10 '23 Buy 42.14 500 21,070 39,622 Nov 14 06:36 PM Bullock John EVP Chief Strategy Officer Sep 01 '23 Option Exercise 28.89 35,772 1,033,453 88,241 Sep 01 05:21 PM STUEWE RANDALL C Chairman and CEO Sep 01 '23 Sale 62.43 100,000 6,243,000 640,363 Sep 05 04:45 PM Bullock John EVP Chief Strategy Officer Sep 01 '23 Sale 61.67 11,532 711,178 52,469 Sep 01 05:21 PM Bullock John EVP Chief Strategy Officer Aug 30 '23 Option Exercise 21.00 34,916 733,236 87,385 Sep 01 05:21 PM Bullock John EVP Chief Strategy Officer Aug 30 '23 Sale 63.13 14,133 892,216 52,469 Sep 01 05:21 PM McNutt Patrick EVP Chief Admin Officer Aug 25 '23 Option Exercise 25.97 1,077 27,974 13,364 Aug 28 04:37 PM van der Velden Jan EVP Int Rendering&Specialties Aug 15 '23 Sale 65.00 1,339 87,035 59,219 Aug 17 04:41 PM Bullock John EVP Chief Strategy Officer Aug 14 '23 Option Exercise 18.82 34,427 647,916 86,896 Aug 16 04:50 PM Bullock John EVP Chief Strategy Officer Aug 14 '23 Sale 65.12 58,600 3,816,142 52,469 Aug 16 04:50 PM Mize Gary W. Director Aug 11 '23 Buy 63.97 1,550 99,154 38,375 Aug 14 04:41 PM Bullock John EVP Chief Strategy Officer Aug 10 '23 Sale 65.10 28,734 1,870,583 101,189 Aug 14 04:38 PM STUEWE RANDALL C Chairman and CEO May 23 '23 Sale 65.00 70,000 4,550,000 740,363 May 25 04:47 PM Barden Larry Director May 11 '23 Buy 63.74 3,000 191,220 16,726 May 12 04:56 PM
Category Global or ExUS Equities - Quant Strat
Asset Type Equities (Stocks)
Tags EAFE
Return% 1Y -
Shs Outstand
Perf Week 0.90%
Sponsor Innovator Management
ETF Type
Tags options
Return% 3Y -
Total Holdings 5
Perf Month 3.09%
Fund Family
Bond Type
Tags buffer
Return% 5Y -
AUM 3.50M
Perf Quarter 9.69%
Index iShares MSCI EAFE ETF
Average Maturity
Tags upside-cap
Return% 10Y
NAV%
Perf Half Y -
Index Weighting
Commodity Type
Tags fixed-period
Return% SI
NAV/sh
Perf Year -
Active/Passive
Quant Type
Tags -
Flows% 1M 24.72%
52W Range 24.97 - 28.03
Perf YTD 3.59%
Dividend TTM -
ESG Type
Tags -
Flows% 3M 24.72%
52W High -0.05%
Beta -
Dividend Ex-Date -
Dividend Type
Sector/Theme
Flows% YTD 24.72%
52W Low 12.19%
ATR (14) 0.09
Expense 0.85%
Structure Type
Region
Flows% 1Y
RSI (14) 71.65
Volatility 0.06% 0.06%
Option/Short No / Yes
Growth/Value
Dev/Emerg
Flows% 3Y
Rel Volume 5.51
Prev Close 28.03
Inverse/Leveraged
Market Cap
Currency
Flows% 5Y
Avg Volume 0.95K
Price 28.01
SMA20 1.35%
SMA50 3.26%
SMA200 4.75%
Trades
Volume 5,212
Change -0.05%
Index -
P/E 255.20
EPS (ttm) 0.72
Insider Own 6.82%
Shs Outstand 55.77M
Perf Week -7.92%
Market Cap 10.26B
Forward P/E 88.60
EPS next Y 2.08
Insider Trans -0.77%
Shs Float 51.97M
Perf Month -6.13%
Income 41.58M
PEG 14.21
EPS next Q 0.30
Inst Own 104.77%
Short Float 9.18%
Perf Quarter 0.11%
Sales 638.76M
P/S 16.06
EPS this Y -16.82%
Inst Trans 1.48%
Short Ratio 8.70
Perf Half Y 14.24%
Book/sh 35.35
P/B 5.20
EPS next Y 42.62%
ROA 1.55%
Short Interest 4.77M
Perf Year 9.75%
Cash/sh 13.47
P/C 13.65
EPS next 5Y 17.96%
ROE 2.14%
52W Range 110.45 - 211.13
Perf YTD 2.29%
Dividend Est. -
P/FCF 136.89
EPS past 5Y 15.08%
ROI 1.59%
52W High -12.89%
Beta 1.02
Dividend TTM -
Quick Ratio 5.75
Sales past 5Y 31.42%
Gross Margin 44.49%
52W Low 66.52%
ATR (14) 5.49
Dividend Ex-Date -
Current Ratio 7.02
EPS Y/Y TTM -77.69%
Oper. Margin 9.71%
RSI (14) 39.12
Volatility 3.08% 2.53%
Employees 1783
Debt/Eq 0.36
Sales Y/Y TTM -20.31%
Profit Margin 6.51%
Recom 1.54
Target Price 210.89
Option/Short Yes / Yes
LT Debt/Eq 0.32
EPS Q/Q -153.51%
Payout 0.00%
Rel Volume 0.62
Prev Close 184.75
Sales Surprise -8.57%
EPS Surprise 1.29%
Sales Q/Q -16.61%
Earnings Feb 21 BMO
Avg Volume 548.00K
Price 183.92
SMA20 -4.98%
SMA50 -5.06%
SMA200 9.28%
Trades
Volume 337,956
Change -0.45%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-04-23 Downgrade
The Benchmark Company
Buy → Hold
Jul-20-23 Initiated
Wells Fargo
Overweight
$185
Jul-05-23 Resumed
JP Morgan
Overweight
$220
Mar-28-23 Initiated
The Benchmark Company
Buy
$230
Dec-14-22 Initiated
Deutsche Bank
Hold
$180
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$190
Jul-20-22 Initiated
UBS
Buy
$213
Oct-14-21 Initiated
Exane BNP Paribas
Outperform
$330
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$241
Aug-24-20 Reiterated
H.C. Wainwright
Buy
$151 → $168
Jun-30-20 Reiterated
H.C. Wainwright
Buy
$143 → $151
May-07-20 Reiterated
H.C. Wainwright
Buy
$100 → $143
Mar-23-20 Reiterated
H.C. Wainwright
Buy
$110 → $100
Nov-15-19 Initiated
Stifel
Buy
Nov-01-19 Upgrade
First Analysis Sec
Outperform → Strong Buy
$107 → $110
Oct-15-19 Initiated
SVB Leerink
Outperform
$100
Aug-28-19 Reiterated
First Analysis Sec
Outperform
$95 → $107
Aug-23-19 Resumed
Stephens
Overweight
Jul-22-19 Upgrade
H.C. Wainwright
Neutral → Buy
$110
Dec-17-18 Upgrade
CL King
Neutral → Buy
Show Previous Ratings
Mar-19-24 07:30AM
Mar-12-24 01:18AM
Feb-27-24 02:02AM
Feb-24-24 12:03AM
Feb-22-24 11:24AM
10:39AM
Loading…
10:39AM
Feb-21-24 08:45AM
08:12AM
07:51AM
(Associated Press Finance)
07:30AM
Feb-07-24 07:30AM
Jan-31-24 12:10PM
Jan-29-24 05:09AM
Dec-19-23 07:30AM
Dec-18-23 04:49AM
07:30AM
Loading…
Dec-07-23 07:30AM
Nov-30-23 11:31AM
Nov-15-23 07:15AM
Nov-14-23 02:01PM
07:30AM
Nov-07-23 07:30AM
Nov-02-23 07:30AM
Nov-01-23 12:10PM
11:46AM
12:04AM
(Thomson Reuters StreetEvents)
Oct-31-23 09:41AM
09:12AM
08:50AM
07:41AM
(Associated Press Finance)
07:30AM
10:01AM
Loading…
Oct-25-23 10:01AM
Oct-24-23 10:00AM
Oct-17-23 11:44AM
07:30AM
Oct-02-23 07:30AM
Sep-27-23 06:51AM
Sep-26-23 12:41PM
(American City Business Journals)
07:30AM
Sep-14-23 10:10AM
Sep-12-23 07:30AM
Sep-06-23 03:06AM
Sep-01-23 12:19PM
11:31AM
07:30AM
Aug-21-23 06:53AM
Aug-17-23 08:00AM
Aug-10-23 09:39AM
Aug-09-23 06:10AM
Aug-03-23 11:19AM
Aug-02-23 08:55AM
07:49AM
07:30AM
Jul-31-23 09:08AM
Jul-26-23 10:02AM
Jul-25-23 11:40AM
Jul-20-23 10:01AM
Jul-19-23 07:30AM
Jul-10-23 08:34AM
Jun-30-23 10:54AM
Jun-21-23 08:00PM
Jun-07-23 11:30AM
Jun-02-23 11:31AM
Jun-01-23 11:31AM
May-31-23 07:30AM
May-30-23 12:09PM
May-09-23 05:52PM
May-03-23 01:20PM
May-02-23 11:36PM
(Thomson Reuters StreetEvents)
08:55AM
07:52AM
07:30AM
07:02AM
May-01-23 07:43AM
Apr-26-23 08:00PM
10:02AM
Apr-25-23 02:07PM
10:01AM
Apr-18-23 07:30AM
Apr-11-23 02:41PM
Mar-24-23 11:30AM
Mar-14-23 07:30AM
Feb-23-23 06:28PM
01:41PM
05:54AM
Feb-22-23 08:55AM
07:30AM
Feb-20-23 06:34AM
Feb-09-23 07:30AM
Feb-08-23 07:30AM
Jan-21-23 09:51AM
Jan-19-23 03:10AM
Jan-13-23 08:30AM
Jan-12-23 05:00PM
11:40AM
Jan-03-23 07:30AM
Dec-21-22 10:56AM
Dec-19-22 09:02AM
Dec-07-22 01:40PM
Dec-01-22 11:31AM
Nov-23-22 11:40AM
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KURIYEL RALF Senior VP, R&D Mar 11 '24 Option Exercise 86.10 1,271 109,433 27,777 Mar 12 08:24 PM KURIYEL RALF Senior VP, R&D Mar 11 '24 Sale 193.73 3,517 681,348 24,260 Mar 12 08:24 PM Hunt Anthony Chief Executive Officer Mar 08 '24 Option Exercise 16.55 1 17 201,956 Mar 11 07:43 PM Hunt Anthony Chief Executive Officer Mar 08 '24 Sale 197.44 16,707 3,298,632 185,249 Mar 11 07:43 PM DAWES KAREN A Director Feb 27 '24 Option Exercise 42.07 4,626 194,616 88,367 Feb 28 09:56 PM DAWES KAREN A Director Feb 27 '24 Sale 193.35 1,000 193,350 87,367 Feb 28 09:56 PM Bylund James Chief Operating Officer Feb 23 '24 Option Exercise 94.33 940 88,670 18,508 Feb 26 08:38 PM Bylund James Chief Operating Officer Feb 23 '24 Sale 198.08 4,373 866,204 14,135 Feb 26 08:38 PM Gebski Christine See Remarks Nov 10 '23 Sale 147.13 3,788 557,328 28,787 Nov 13 05:10 PM DAWES KAREN A Director Aug 29 '23 Option Exercise 18.12 7,392 133,943 84,591 Aug 30 04:06 PM DAWES KAREN A Director Aug 29 '23 Sale 171.38 850 145,673 83,741 Aug 30 04:06 PM Madaus Martin D Director May 08 '23 Buy 156.18 500 78,090 1,611 May 08 09:15 PM Madaus Martin D Director May 05 '23 Buy 159.19 500 79,595 1,111 May 08 09:15 PM Madaus Martin D Director May 04 '23 Buy 161.15 500 80,575 611 May 08 09:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite